World
GLP-1s must now include warning for potential increased risk of The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
Chuck ODonnellCorrespondentPublished Nov 9, 2026 at 7:51 PM EST · 1 min read
GLP-1s must now include warning for potential increased risk of The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss. The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
Continue reading
Latest →Corrections, sourcing and article labels are part of the publication record. See our editorial standards.